Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy.
Hum Genomics
; 17(1): 43, 2023 05 18.
Article
in En
| MEDLINE
| ID: mdl-37202799
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Breast Neoplasms
Type of study:
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Year:
2023
Type:
Article